Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

B12 10mg Dosage Chart & Reconstitution - Dosage Peptide

B12 (10mg Vial) Dosage Protocol Vitamin B12 (cyanocobalamin) — a water-soluble methylation and energy-metabolism cofactor; presented for research and educational use. Mix & measure Vitamin B12 · 10 mg Pre-filled with this protocol’s recommended BAC water and d

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

B12 (10mg Vial) Dosage Protocol

Vitamin B12 (cyanocobalamin) — a water-soluble methylation and energy-metabolism cofactor; presented for research and educational use.

Mix & measure Vitamin B12 · 10 mg

Pre-filled with this protocol’s recommended BAC water and documented starting dose — edit any field to run your own numbers.

Reconstitution math only — not dosing advice. U-100 syringe: 100 units = 1 mL. Full reconstitution guide → · Advanced calculator →

Dosing & Reconstitution Guide

A single practical dilution with once-weekly maintenance dosing, step by step

Standard Approach (2 mL = 5 mg/mL)

Reconstitute: Add 2.0 mL bacteriostatic water to one 10 mg vial → final concentration 5 mg/mL (5,000 mcg/mL).

Typical range: 1,000 mcg (1 mg) per dose, once weekly for maintenance, after an optional 1–2 week loading phase.

Easy measuring: At 5 mg/mL, 1 unit = 0.01 mL = 50 mcg on a U-100 syringe, so units = mcg ÷ 50. A 1,000 mcg dose equals 20 units (0.20 mL).

Storage: Lyophilized: store cool, dry and dark; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) protected from light — B12 is light-sensitive — and do not freeze the mixed solution.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01Dihexa — frequently asked questions

Dihexa is taken by mouth as one or more capsules once daily, swallowed whole with or without food. There is no mixing, reconstitution, or injection — it is an oral small-molecule compound, not an injectable peptide. No. Because Dihexa is an oral capsule, none of the injectable-peptide supplies (bacteriostatic water, insulin syringes, alcohol swabs) apply — you simply take the capsule(s) by mouth. Each capsule is a fixed strength, so a target dose is reached by taking the matching number of capsules at that strength. The dosing table on this page lists the reference dose for each step of a documented research schedule — match your capsule strength to it rather than assuming a fixed number. Keep the capsules in their original sealed container at controlled room temperature, dry and away from heat, light and moisture, and follow the specific storage guidance supplied with your product. No refrigeration or reconstitution is required. The main practical difference is the route of administration: Dihexa is swallowed as a capsule, so there is no reconstitution, bacteriostatic water, or sterile injection technique involved. Its specific mechanism of action and the research behind it are described in the "How This Works" section on this page. No. Research-grade Dihexa is supplied strictly for laboratory and research purposes and is not an approved medicine for human use — regardless of whether an approved pharmaceutical product containing this ingredient exists. Everything here is research information, not medical advice; consult a licensed healthcare professional and the approved product labeling before any use.

Source: dosagepeptide.com ↗
02Matrixyl 3000 — frequently asked questions

Matrixyl 3000 is a topical cosmetic peptide applied to the skin as part of a serum or cream — not injected or taken by mouth. It is blended into a water-based base at a chosen percentage and applied to clean skin. Cosmetic formulations commonly use roughly 3 to 10 percent. Higher is not necessarily better and can affect texture, stability and skin tolerability. The strength shown on this page is a formulation reference, not a dose to inject. No. As a topical peptide, none of the injectable-peptide supplies (bacteriostatic water, insulin syringes, alcohol swabs) apply — it is dissolved into a serum or cream base and applied to the skin. Keep the raw powder sealed, cool, dry and away from light. A finished water-based peptide serum is best refrigerated and used within a few weeks, since peptides in solution degrade over time. No. Matrixyl 3000 is a cosmetic-grade ingredient for topical formulation and research, not an approved medicine; the evidence supports only modest topical, cosmetic effects. Everything here is research and educational information, not medical advice.

Source: dosagepeptide.com ↗
03Tesofensine — frequently asked questions

Tesofensine is taken by mouth as one or more capsules once daily, swallowed whole with or without food. There is no mixing, reconstitution, or injection — it is an oral small-molecule compound, not an injectable peptide. No. Because Tesofensine is an oral capsule, none of the injectable-peptide supplies (bacteriostatic water, insulin syringes, alcohol swabs) apply — you simply take the capsule(s) by mouth. Each capsule is a fixed strength, so a target dose is reached by taking the matching number of capsules at that strength. The dosing table on this page lists the reference dose for each step of a documented research schedule — match your capsule strength to it rather than assuming a fixed number. Keep the capsules in their original sealed container at controlled room temperature, dry and away from heat, light and moisture, and follow the specific storage guidance supplied with your product. No refrigeration or reconstitution is required. The main practical difference is the route of administration: Tesofensine is swallowed as a capsule, so there is no reconstitution, bacteriostatic water, or sterile injection technique involved. Its specific mechanism of action and the research behind it are described in the "How This Works" section on this page. No. Research-grade Tesofensine is supplied strictly for laboratory and research purposes and is not an approved medicine for human use — regardless of whether an approved pharmaceutical product containing this ingredient exists. Everything here is research information, not medical advice; consult a licensed healthcare professional and the approved product labeling before any use.

Source: dosagepeptide.com ↗
04Argireline — frequently asked questions

Argireline is a topical cosmetic peptide applied to the skin as part of a serum or cream — not injected or taken by mouth. It is blended into a water-based base at a chosen percentage and applied to clean skin. Cosmetic formulations commonly use roughly 3 to 10 percent. Higher is not necessarily better and can affect texture, stability and skin tolerability. The strength shown on this page is a formulation reference, not a dose to inject. No. As a topical peptide, none of the injectable-peptide supplies (bacteriostatic water, insulin syringes, alcohol swabs) apply — it is dissolved into a serum or cream base and applied to the skin. Keep the raw powder sealed, cool, dry and away from light. A finished water-based peptide serum is best refrigerated and used within a few weeks, since peptides in solution degrade over time. No. Argireline is a cosmetic-grade ingredient for topical formulation and research, not an approved medicine; the evidence supports only modest topical, cosmetic effects. Everything here is research and educational information, not medical advice.

Source: dosagepeptide.com ↗
05Enclomiphene — frequently asked questions

Enclomiphene is taken by mouth as one or more capsules once daily, swallowed whole with or without food. There is no mixing, reconstitution, or injection — it is an oral small-molecule compound, not an injectable peptide. No. Because Enclomiphene is an oral capsule, none of the injectable-peptide supplies (bacteriostatic water, insulin syringes, alcohol swabs) apply — you simply take the capsule(s) by mouth. Each capsule is a fixed strength, so a target dose is reached by taking the matching number of capsules at that strength. The dosing table on this page lists the reference dose for each step of a documented research schedule — match your capsule strength to it rather than assuming a fixed number. Keep the capsules in their original sealed container at controlled room temperature, dry and away from heat, light and moisture, and follow the specific storage guidance supplied with your product. No refrigeration or reconstitution is required. The main practical difference is the route of administration: Enclomiphene is swallowed as a capsule, so there is no reconstitution, bacteriostatic water, or sterile injection technique involved. Its specific mechanism of action and the research behind it are described in the "How This Works" section on this page. No. Research-grade Enclomiphene is supplied strictly for laboratory and research purposes and is not an approved medicine for human use — regardless of whether an approved pharmaceutical product containing this ingredient exists. Everything here is research information, not medical advice; consult a licensed healthcare professional and the approved product labeling before any use.

Source: dosagepeptide.com ↗
comparison

Injectable Versus Oral: Which Route Is Right?

For most of the class’s history, GLP-1 drugs had to be injected because peptides are digested and destroyed in the stomach. That constraint is now loosening, and the route of administration…

Source: dosagepeptide.com
comparison

Hypertrophy vs Hyperplasia: What the Myonuclear-Domain Debate Really Says

No section is more misused in recovery marketing than the relationship between satellite cells and muscle growth. The hypertrophy vs hyperplasia research distinction and the myonuclear-doma…

Source: dosagepeptide.com
Research context

Read sources and limitations before applying a claim.

The honest bottom line: what the research actually shows

Stripped of marketing and the seductive name, here is what the DSIP literature supports: DSIP is real and well-characterized as a molecule. The nonapeptide WAGGDASGE was genuinely isolated during rigorous sleep-physiology experiments and its structure and synthesis are solid.[1][2] The core sleep claim is weak. Human sleep evidence is old, small, inconsistent, and largely lineage-linked; independent replication is poor; and a within-field review flatly called the sleep hypothesis “poorly documented and still weak.”[5] Mechanisms are hypotheses. No receptor, no confirmed precursor, no closed pathway; the HPA-axis story in particular failed in controlled human testing.[9] Non-sleep effects are a separate story. Antioxidant, geroprotective, and neuroprotective findings exist in animal models but say nothing about human sleep and should not be used to prop up the sleep claim.[10] It is not approved and not proven. DSIP is an investigational research peptide with no regulatory approval and no rigorous long-term human safety data. If there is a single sentence to take away, it is this: DSIP is a molecule whose reputation was set by its name and its dramatic discovery story, not by a body of reproducible evidence that it improves sleep. The intellectually honest position is that DSIP is a fascinating, unresolved chapter in sleep neuroscience — a molecule that earned an ambitious name it has never quite lived up to. It is a legitimate subject of continued research, especially given the intriguing preclinical work on cellular protection and injury. It is not a demonstrated sleep therapy. Anyone evaluating DSIP for laboratory research should treat the sleep-benefit narrative with appropriate skepticism and let the actual evidence — small, dated, and inconsistent — set the expectation. For those conducting formal research who need accurate handling and measurement information for the compound, the DSIP research reference and handling guide is the appropriate resource, always used strictly within a research-only, non-therapeutic framework and alongside the honest evidence picture laid out above.

Source: dosagepeptide.com ↗

What does clinical research say about comparing the B12 forms head to head?

Setting genetics aside for a moment, it is worth asking what controlled research shows when the forms are simply compared in people. The answer is that differences exist but are modest, dose-dependent, and rarely decisive — and, importantly, the comparisons were generally not stratified by genotype.

Source: dosagepeptide.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Why does cagrilintide only need weekly dosing?

Native amylin lasts only minutes and aggregates readily. Cagrilintide is lipid-modified so it binds reversibly to serum albumin, creating a slow-release depot that greatly prolongs its residence in the body. This produces steady, sustained activation of amylin receptors across a week, unlike meal-time agents such as pramlintide, and it aligns cagrilintide with weekly GLP-1 agonists for combination use.

Source: dosagepeptide.com ↗
Storage reference

Transport, Storage, and Turnover

In circulation, cobalamin is carried on transcobalamin (the fraction available for cellular uptake, sometimes called holotranscobalamin or “active B12”) and on haptocorrin. Cellular uptake occurs via the transcobalamin receptor. The body stores a comparatively enormous amount — on the order of 1–5 milligrams, mostly in the liver — against a daily loss of only a few micrograms. Because of this large reserve and efficient enterohepatic recycling, it can take years for deficiency to develop after intake stops, which is another reason acute “topping up” a replete person has no metabolic urgency.

Source: dosagepeptide.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →